Correlation Between Seelos Therapeutics and Bio Path
Can any of the company-specific risk be diversified away by investing in both Seelos Therapeutics and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seelos Therapeutics and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seelos Therapeutics and Bio Path Holdings, you can compare the effects of market volatilities on Seelos Therapeutics and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seelos Therapeutics with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seelos Therapeutics and Bio Path.
Diversification Opportunities for Seelos Therapeutics and Bio Path
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Seelos and Bio is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Seelos Therapeutics and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Seelos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seelos Therapeutics are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Seelos Therapeutics i.e., Seelos Therapeutics and Bio Path go up and down completely randomly.
Pair Corralation between Seelos Therapeutics and Bio Path
Given the investment horizon of 90 days Seelos Therapeutics is expected to under-perform the Bio Path. In addition to that, Seelos Therapeutics is 2.36 times more volatile than Bio Path Holdings. It trades about -0.5 of its total potential returns per unit of risk. Bio Path Holdings is currently generating about -0.25 per unit of volatility. If you would invest 108.00 in Bio Path Holdings on August 29, 2024 and sell it today you would lose (28.00) from holding Bio Path Holdings or give up 25.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 77.27% |
| Values | Daily Returns |
Seelos Therapeutics vs. Bio Path Holdings
Performance |
| Timeline |
| Seelos Therapeutics |
| Bio Path Holdings |
Seelos Therapeutics and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seelos Therapeutics and Bio Path
The main advantage of trading using opposite Seelos Therapeutics and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seelos Therapeutics position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Seelos Therapeutics vs. Rezolute | Seelos Therapeutics vs. Tempest Therapeutics | Seelos Therapeutics vs. Forte Biosciences | Seelos Therapeutics vs. Dyadic International |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |